Rituxan Warnings and Precautions

Make sure your healthcare provider is aware of any other medical problems you have, such as diabetes, any kind of infection, or cold sores before beginning treatment with Rituxan. This product can cause drug interactions, so tell your healthcare provider about any other medications you are taking. Other precautions and warnings with Rituxan apply to women who are pregnant or breastfeeding.

What Should I Tell My Healthcare Provider?

Prior to receiving an infusion of Rituxan® (rituximab), tell your healthcare provider if you have:
 
  • A history of tuberculosis or hepatitis B
  • Any current infection
  • Infections that come and go (such as cold sores)
  • Any disease that affects the immune system, such as diabetes, cancer, HIV, or AIDS
  • Plans to receive vaccinations
  • An irregular heart rhythm (arrhythmia)
  • A certain type of chest pain known as angina
  • Any allergies, including to foods, dyes, or preservatives.
     
Also, let your healthcare provider know if you are:
 
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
     
Make sure to tell your healthcare provider about any other medicines you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.
 

Specific Precautions and Warnings With Rituxan

Some warnings and precautions to be aware of prior to receiving Rituxan include the following:
 
  • Infusion reactions are common with Rituxan. However, appropriate "premedication" can help limit the chance and severity of such problems. Premedication often includes acetaminophen (Tylenol®), an antihistamine, and a steroid. Infusion reactions can range from mild to fatal and may include the following symptoms:
     
 
  • When Rituxan is used to treat non-Hodgkin's lymphoma, it can sometimes cause tumor lysis syndrome, a group of serious symptoms that occurs when too many cancer cells die and are broken down at once. This most commonly occurs 12 to 24 hours after the first Rituxan dosage. Your healthcare provider should monitor you carefully and aggressively treat this condition with medications, IV fluids, and possibly even dialysis if it occurs.
     
  • There have been reports of kidney failure in people who were given Rituxan. This can occur either due to tumor lysis syndrome or possibly as the result of drug interactions between Rituxan and cisplatin (a chemotherapy medication). Your healthcare provider may want to monitor your kidney function to check for this problem using a simple blood test.
     
  • Rituxan can cause dangerous skin or mucous membrane reactions. These reactions can lead to significant tissue damage, disfigurement, and even death. Make sure to let your healthcare provider know right away if you develop any sort of rash or blistering anywhere on your body. These reactions have occurred anywhere from 1 to 13 weeks after a dose of Rituxan.
     
  • In rare cases, people receiving Rituxan have contracted JC virus infections that led to a serious condition known as progressive multifocal leukoencephalopathy (PML). Let your healthcare provider know if you develop any signs or symptoms of PML, such as:
     
    • Headaches
    • Coordination problems
    • Speech difficulties
    • Memory loss.
 
  • People who are carriers for hepatitis B may experience a reactivation of the virus while receiving Rituxan. This can be quite serious -- potentially even fatal. If you have ever had hepatitis B, your healthcare provider will need to monitor you closely to make sure the virus is not becoming reactivated. Because people may not know if they've had a hepatitis B infection, everyone should be tested before starting this drug.
     
  • This medication may increase the risk of serious infections. Your healthcare provider may advise against using Rituxan if you currently have an infection or are prone to recurrent infections, if you have a condition that increases your risk for infections, or if you have recently been exposed to a serious infection.
     
  • Rituxan can cause an irregular heart rhythm (arrhythmia). In some cases, these arrhythmias may be dangerous. If you develop an arrhythmia while receiving this drug, if you have had an arrhythmia in the past, or if you have a type of chest pain known as angina, your healthcare provider should monitor your heart rhythm while you are receiving an infusion and for a while afterwards.
     
  • There have been rare reports of intestinal blockage (obstruction) or perforation in people who were given Rituxan in combination with chemotherapy. Make sure to let your healthcare provider know immediately if you develop signs or symptoms of such problems, such as:
     
    • A sudden change in bowel habits
    • Vomiting
    • Fever
    • Abdominal pain (stomach pain).
 
  • You should probably not receive live vaccines while using this drug. Talk to your healthcare provider before receiving any vaccines while on Rituxan.
     
  • Rituxan can potentially interact with a few other medications (see Rituxan Drug Interactions).
     
  • Rituxan is considered a pregnancy Category C medication. This means that it may not be safe for use during pregnancy, although the full risks are not currently known (see Rituxan and Pregnancy).
     
  • It is unknown if this medication passes through breast milk in humans. Therefore, please check with your healthcare provider before receiving it while breastfeeding (see Rituxan and Breastfeeding).
     
Top Foods to Fight Inflammation

Rituxan Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.